ArticlePharmaceutics2024

Iron Oxide Nanoparticles: Selectively Targeting Melanoma Cells In Vitro by Inducing DNA Damage via H2AX Phosphorylation and Hindering Proliferation through ERK Dephosphorylation.

Danai E Prokopiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.